- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Pioneer in Cancer Immunotherapy Receives Federal Award
Steven Rosenberg, MD, chief of surgery at NCI's Center for Cancer Research, has been awarded the 2015 Samuel J. Heyman Service to America Medal, or Sammie for his contributions to the field of immune-based cancer treatments.
The Partnership for Public Service awards Samuel J. Heyman Service to America Medal, or Sammie, to federal employees with significant contributions to the health and well-being of Americans. This year, Steven Rosenberg, MD, chief of the Surgery Branch in the National Cancer Institute's Center for Cancer Research is one of 8 federal employees to be honored this year.
Dr Rosenberg, through his research efforts, identified the important role of T cells and interleukin-2 in patients with advanced cancer who were refractory to standard treatments. Additionally, he has contributed significantly to the field of adoptive cell transfer, a procedure that engineers the patient's own T-cells to attack the tumor (also known as CAR-T cells).
Read more here.
High HSP60 Expression Signals Poor Prognosis, Aggressive Tumors in Ovarian Cancer
January 16th 2025High heat shock protein 60 (HSP60) expression in patients with ovarian cancer is associated with larger tumors, advanced stages, and worse survival outcomes, highlighting its potential as a prognostic biomarker.
Read More
Real-World Evidence Confirms the Benefits of JAK Inhibitors in Patients With Rheumatoid Arthritis
January 16th 2025This systematic review of real-world observational studies demonstrated the effectiveness of Janus kinase (JAK) inhibitors in improving treatment adherence, persistence, clinical outcomes, and patient-reported outcomes among US patients with rheumatoid arthritis.
Read More
